在早期和转移性NSCLC中针对性治疗选择-概述
Gabriella Gálffy1, Éva Morócz1, Réka Korompay1
1Pulmonology Hospital Törökbálint, Törökbálint, Hungary.
Pathology oncology research : POR
|April 12, 2024
概括
最近非小细胞肺癌 (NSCLC) 治疗的进展包括针对KRAS G12C和其他突变的向疗法. 下一代测序 (NGS) 有助于识别这些变化,以提供个性化护理.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 治疗策略已经显著发展.
- 免疫疗法,化疗和向疗法改善了无病生存率和整体生存率.
- 特定的NSCLC分子变化,如EGFR突变和融合,是个性化医学的目标.
研究的目的:
- 审查针对NSCLC的向治疗的不断扩大的领域.
- 要突出最近对突变的批准,包括KRAS G12C,EGFR外20,HER2和MET.
- 强调下一代测序 (NGS) 在识别可操作目标中的作用.
主要方法:
- 审查最近的FDA和EMA对NSCLC的向药物的批准.
- 对新型向疗法的临床试验数据的分析.
- 讨论分子分析 (包括NGS) 对治疗选择的影响.
主要成果:
- 现在可以针对EGFR,BRAF,ALK,ROS1,NTRK,RET,KRAS G12C,EGFR外子20,HER2和MET突变/融合进行向治疗.
- 索托拉西布和阿达格拉西布已被批准用于KRAS G12C突变NSCLC,组合疗法显示有前途.
- 阿米万达尼布,特拉斯图祖马布德鲁克斯泰坎,卡普马提尼布和特波提尼布已被批准用于特定突变,如EGFR外因子20的跳转,HER2的跳转和MET外因子14的跳转.
结论:
- 针对性治疗的可用性显著改善了瘤成性转移性NSCLC患者的治疗结果.
- 以NGS等分子分析为指导的个性化治疗策略对于优化NSCLC护理至关重要.
- 目前正在进行的研究和开发继续扩大NSCLC患者的治疗选择,这些患者具有多种分子变异.
更多相关视频
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.0K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522